- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Healthy Participants With Moderate and High Cardiovascular Risk in Canada
Total 19 results
-
Novartis PharmaceuticalsTerminatedMyelofibrosis With High Molecular Risk MutationsBelgium, Spain, United Kingdom, Hungary, Italy, Japan, Taiwan, Germany, Canada, Singapore, Austria, Australia, France, Israel, Sweden, Switzerland, Hong Kong, Greece, Turkey, Brazil, Russian Federation, Denmark, Portugal, Norway, Poland
-
BayerCompletedModerate Risk of CVDPoland, United States, Italy, United Kingdom, Germany, Spain, Puerto Rico, Ireland
-
Canadian Medical and Surgical Knowledge Translation...Unity Health Toronto; Western University, Canada; HLS Therapeutics, IncCompletedCardiovascular Diseases | Diabetes Mellitus, Type 2 | Cardiovascular Risk Factor | Triglycerides HighCanada
-
Alnylam PharmaceuticalsRecruitingHypertension | High Cardiovascular RiskUnited States, Canada
-
Maisonneuve-Rosemont HospitalCompletedMultiple Myeloma | High-Risk CancerCanada
-
Biosensors Europe SAActive, not recruitingAcute Coronary Syndrome | High Bleeding RiskUnited States, Canada, France, Italy, United Kingdom, Germany, Denmark
-
University of TorontoCanadian Institutes of Health Research (CIHR)CompletedCardiovascular Diseases | Hypertension | Healthy | Obesity | Diabetes | Overweight | Metabolic Syndrome | PreDiabetes | Overweight and Obesity | Cardiovascular Risk Factor | DysglycemiaCanada
-
University of ManitobaCanadian Anesthesia Research FoundationUnknownMyocardial Infarction | Delirium | Respiratory Failure | Death | Postoperative Infection | Kidney Injury | High Risk Non-cardiac SurgeryCanada
-
BayerActive, not recruitingHot Flashes | Vasomotor Symptoms Caused by Adjuvant Endocrine Therapy in Women With, or at High Risk for Developing Hormone-receptor Positive Breast CancerSpain, France, Belgium, United Kingdom, Hungary, Israel, Italy, Ireland, Germany, Portugal, Finland, Poland, Romania, Canada, Austria, Kazakhstan
-
Regenera Pharma LtdCompletedMild to Moderate Dementia Due to Alzheimer's Disease | With or Without Coexisting Cerebrovascular DiseaseCanada
-
AstraZenecaThe Cleveland Clinic; IQVIA RDS Inc.CompletedEligible Men or Women Considered High Risk for Atherosclerotic Cardiovascular Disease (CVD)United States, Belgium, Italy, Netherlands, Denmark, Taiwan, Poland, Russian Federation, Korea, Republic of, Hungary, United Kingdom, China, New Zealand, Czechia, Australia, South Africa, Ukraine, Japan, Canada, Mexico, Lithuania, Estoni...
-
ECRI bvUniversity of Bern; European Cardiovascular Research Center; Terumo Medical Corporation and other collaboratorsCompletedCoronary Artery Disease | PCI | High Bleeding RiskNetherlands, France, United Kingdom, Australia, Singapore, Japan, Italy, Poland, Spain, Switzerland, Israel, Argentina, Austria, Bahrain, Bangladesh, Belgium, Bulgaria, Czechia, Denmark, Estonia, Germany, Hungary, India, Korea, Republic... and more
-
Eisai Inc.Thrombolysis In Myocardial Infarction (TIMI) Academic Research OrganizationCompletedObesity | Cardiovascular Disease | Overweight | Type 2 Diabetes | High Cardiovascular RiskUnited States, Canada, Poland, Australia, Mexico, New Zealand, Bahamas, Chile
-
University of TorontoUnited Soybean BoardActive, not recruitingCardiovascular Diseases | Hypertension | Obesity | Diabetes | Overweight | Metabolic Syndrome | Dyslipidemias | PreDiabetes | Overweight and Obesity | Dysglycemia | Healthy Obesity, Metabolically | Heart Disease Risk FactorsCanada
-
AstraZenecaBristol-Myers Squibb; Hadassah Medical Organization; The TIMI Study GroupCompletedDiabetes Mellitus, Non-Insulin-Dependent | High Risk for Cardiovascular EventUnited States, Canada, France, Italy, Netherlands, Spain, Belgium, Thailand, Vietnam, Bulgaria, Korea, Republic of, Brazil, Philippines, Russian Federation, Turkey, Taiwan, Australia, Israel, South Africa, Germany, Japan, Czechia, H... and more
-
Novartis PharmaceuticalsCompletedHearth Failure With Reduced Ejection Fraction (HFrEF)Canada
-
Population Health Research InstituteCanadian Institutes of Health Research (CIHR); Heart and Stroke Foundation...RecruitingCardiovascular Diseases | Lung Diseases | Cancer | Risk Factor, Cardiovascular | Health Behavior | Injuries | Environmental Exposure | Renal Disease | Communicable DiseaseIndia, Saudi Arabia, Iran, Islamic Republic of, Peru, Pakistan, Argentina, Bangladesh, Brazil, Canada, Chile, China, Colombia, Kazakhstan, Kyrgyzstan, Malaysia, Palestinian Territory, occupied, Philippines, Poland, Russian Federation and more
-
BayerRecruitingAcute Non-cardioembolic Ischemic Stroke | Prevention of Ischemic Stroke | High-risk Transient Ischemic AttackUnited States, Switzerland, Belgium, Sweden, Canada, Australia, Taiwan, Spain, Korea, Republic of, Latvia, Israel, Malaysia, Greece, Japan, Turkey, Netherlands, Romania, China, United Kingdom, Portugal, Italy, Brazil, France, Slovakia, ... and more
-
Karyopharm Therapeutics IncActive, not recruitingAcute Myeloid Leukemia (AML) | Metastatic Colorectal Cancer (mCRC) | Metastatic Castration-Resistant Prostate Cancer (mCRPC) | Relapsed/Refractory Multiple Myeloma (RRMM) | Higher-Risk Myelodysplastic Syndrome (HR-MDS) | Newly Diagnosed Intermediate/High-Risk MDSUnited States, France, Canada, Spain, China